In particular, the continuous treatment effectiveness and safety of both amphetamine and methylphenidate have been demonstrated in controlled drug trials with durations of several years.
It is a rigid analogue of phenylisobutylamine and substitutes amphetamine for it in rat discrimination tests, although at approximately one fourth the potency.
